Gefitinib Accord

Gefitinib Accord is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Accord Healthcare B.V. and is designed for targeted therapy.

Gefitinib Accord is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic markers. It works by targeting and inhibiting the growth of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced or metastatic NSCLC where other treatments have failed.

Common effects of Gefitinib Accord may include skin rash, diarrhea, and nausea. Some users may experience fatigue or loss of appetite. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Gefitinib Accord should be handled with care, especially by pregnant women or those planning to become pregnant. It is important to follow the prescribed dosage and administration guidelines. Store the medication as directed to maintain its efficacy.

Gefitinib Accord may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider.